Bioleaders Corporation (KOSDAQ:A142760) announced a private placement of series 7 non-guaranteed private convertible bonds with bearer interest for gross proceeds of KRW 13,000,000,000 on February 16, 2021.The bonds do not have any annual coupon and have no yield to maturity .The maturity date of bonds is February 18, 2026. The bonds are 100% convertible into 2,263,231 common shares representing 8.26% stake in the company at a conversion price of KRW 5,744 from February 18, 2022 to January 18, 2026. The payment date is February 18, 2021. The transaction has been approved by the board of directors of the company. The transaction included participation from Mirae Asset Daewoo Co., Ltd., Investment Arm for KRW 2,000,000,000, DB Financial Investment Co.,Ltd., Investment Arm for KRW 1,000,000,000, Hanyang Securities Co., Ltd., Investment Arm for KRW 500,000,000, Orion Asset Management Co., Ltd for KRW 2,000,000,000, Lee Hyun Asset Management Co., Ltd. for KRW 1,500,000,000, A One Asset Management Co., Ltd for KRW 1,500,000,000, C Square Asset Management Co., Ltd. for KRW 1,000,000,000, Tiger Asset Management Investment Co., Ltd. for KRW 1,000,000,000, Assem Asset Management Co., Ltd. KRW 1,000,000,000, Cha Partners Asset Management Co., Ltd. for KRW 1,000,000,000 and Bluetech Asset Management Co., Ltd for KRW 500,000,000.